肿瘤细胞治疗研究
ALL SOURCES
The IL-1R and NFKBIZ pathway mediates immunoregulatory responses and immunotherapy efficacy in anaplastic large cell lymphoma.
我们的发现揭示了一种新的免疫抵抗机制，并表明IL-1R阻断是一种有前景的联合策略，可改善ALCL中基于CAR的免疫治疗。
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE i
第七届多利益相关方儿科战略论坛聚焦于针对儿童和青少年癌症的嵌合抗原受体（CAR）T细胞。
Epstein-Barr virus-positive T- and NK-cell lymphoproliferative disorders: Report from the 2023 SH/EA4HP Lymphoma Workshop.
EBV+ T细胞和NK细胞LPDs的诊断复杂，需结合临床信息及形态学和分子特征的多参数方法。
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
